Company News Summary
CSL Provides Chairman's Address to Shareholders at AGM
14 Oct 2020 | 09:47:00 | Associate analysts | Increase | Decrease | 
Original announcement: Chairman's Address to Shareholders
CSL provided Chairman's address to shareholders at AGM. It continued strong demand for plasma and recombinant products. The construction of its new 16-storey global R&D hub facility and corporate headquarters in the heart of Melbourne's biomedical precinct is tracking along well, scheduled to open in 2023. Seqirus delivered on its product differentiation strategy with profit growth, driven by influenza sales which were up 21%.
See more ASX300 News Announcements